Research Topics
| Magdalena E SobieszczykSummaryAffiliation: Columbia University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Combining Google Earth and GIS mapping technologies in a dengue surveillance system for developing countriesAileen Y Chang
Department of Vector Borne Disease, Nicaraguan Ministry of Health, Managua, Nicaragua
Int J Health Geogr 8:49. 2009..A surveillance system using Google Earth and GIS mapping technologies was developed in Nicaragua as a management tool...
Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infectionsMagdalena E Sobieszczyk
Department of Medicine, Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, 630 W 168th Street, PH 8W 876, New York, NY 10032, USA
J Antimicrob Chemother 54:566-9. 2004..The treatment of infections caused by multidrug-resistant (MDR) Gram-negative organisms poses a therapeutic challenge. The use of polymyxin B has been resurrected specifically for this purpose...
Engaging members of African American and Latino communities in preventive HIV vaccine trialsMagdalena E Sobieszczyk
Department of Medicine, Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
J Acquir Immune Defic Syndr 51:194-201. 2009..The success in engaging and enrolling AAs and Latinos in phase 1 and phase 2 vaccine trials at 2 research sites in New York City is described...
Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV StudyMagdalena E Sobieszczyk
Division of Infectious Diseases, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
J Acquir Immune Defic Syndr 48:272-80. 2008..To assess the prevalence of metabolic syndrome (MetSynd) among participants of the Women's Interagency HIV Study and to describe the association of MetSynd with HIV infection, antiretroviral therapies, and sociodemographic factors...
Advances in antiretroviral therapyMagdalena E Sobieszczyk
Columbia University Medical Center, New York, NY, USA
Top HIV Med 14:36-62. 2006....
The challenge of HIV-1 subtype diversityBarbara S Taylor
Department of Medicine and the Division of Infectious Diseases, Columbia University Medical Center, New York 10032, USA
N Engl J Med 358:1590-602. 2008
Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjectsLindsey R Baden
Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts, MA, USA
J Infect Dis 204:1541-9. 2011....
Advances in antiretroviral therapyMagdalena E Sobieszczyk
Columbia University College of Physicians and Surgeons, New York, NY, USA
Top HIV Med 13:24-44. 2005..This review will highlight the major findings relevant to clinicians and clinical investigators...
Advances in antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USAMagdalena E Sobieszczyk
Columbia University College of Physicians and Surgeons, New York, NY, USA
Top HIV Med 12:9-29. 2004..This reviews summarizes new information relevant to clinicians and clinical researchers...
Host genetic polymorphisms associated with innate immune factors and HIV-1Magdalena E Sobieszczyk
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA
Curr Opin HIV AIDS 6:427-34. 2011....
Anaemia in acute HIV-1 subtype C infectionKoleka Mlisana
Centre for the AIDS Programme of Research in South Africa CAPRISA, University of KwaZulu Natal, Durban, South Africa
PLoS ONE 3:e1626. 2008....
